¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute phase reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • fuchsinophil reaction
    Ç«½Åģȭ¹ÝÀÀ
  • gel diffusion precipitin reaction
    °ÖÈ®»êħÀü¹ÝÀÀ
  • gluteal reaction
    º¼±â¹ÝÀÀ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • grief reaction
    ¾Öµµ¹ÝÀÀ
  • gross stress reaction
    ´ëÀڱعÝÀÀ, ÃÑüÀû½ºÆ®·¹½º¹ÝÀÀ
  • hyperkinetic reaction
    ¿îµ¿°ú´Ù¹ÝÀÀ
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypnic reaction
    ¼ö¸é¹ÝÀÀ
  • hysteric reaction
    È÷½ºÅ׸®¹ÝÀÀ
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • hemoclastic reaction
    Ç÷±¸ÆÄ±«¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
  • Herxheimer¡¯s reaction
    Ç츣ũ½ºÇÏÀ̸ӹÝÀÀ
  • heterogeneous reaction
    ÀÌÁú¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • fuchsinophil reaction
    Ç«½Åģȭ¹ÝÀÀ
  • reaction fever
    ¹ÝÀÀ¿­
  • reaction formation
    ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
  • gel diffusion precipitin reaction
    ¿ì¹«È®»êħÀü¹ÝÀÀ
  • gluteal reaction
    º¼±â¹ÝÀÀ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • grief reaction
    ¾Öµµ¹ÝÀÀ, ºñ¾Ö¹ÝÀÀ
  • gross stress reaction
    ´ëÀڱعÝÀÀ, ÃÑüÀû½ºÆ®·¹½º¹ÝÀÀ
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • hemoclastic reaction
    Ç÷±¸ºØ±«¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼öÇ÷¹ÝÀÀ
  • Herxheimer¡¯s reaction
    (¢¡Jarisch-Herxheimer reaction) ¾ß¸®½ÃÇ츤½ºÇÏÀ̸ӹÝÀÀ
  • heterogeneous reaction
    ºÒ±ÕÀϹÝÀÀ, ºÒ±ÕÁú¹ÝÀÀ
  • heterophil antibody reaction
    ÀÌÁ¾Ä£È­Ç×ü¹ÝÀÀ
  • homograft reaction
    µ¿Á¾À̽ĹÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • rage reaction
    ³ë¹ÝÀÀ(ÖÍÚãëë).
  • rate limiting reaction
    ¼ÓµµÁ¦ÇѹÝÀÀ.
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼(Úãëë õµòäô÷).
  • reaction center
    Ȱ¼ºÁß½É(üÀàõñéãý).
  • reaction deficiency
    ¹ÝÀÀ°áÇÌ
  • reaction fever
    ¹ÝÀÀ¿­(Úãëëæð).
  • reaction formation
    ¹ÝÀÀÇü¼º(Úãëëû¡à÷).(Á¤½Å)¹Ýµ¿Çü¼º(ÚãÔÑû¡à÷).
  • reaction isochore
    ¹ÝÀÀÇ׿ë½Ä(ÚãëëùöéÄãÒ).
  • reaction kinetics
    ¹ÝÀÀ¼Óµµ·Ð(ÚãëëáÜöôÖå).
  • reaction of identity
    ÀÏÄ¡¹ÝÀÀ
  • reaction of non-identity
    ºÒÀÏÄ¡¹ÝÀÀ
  • reaction of partial identity
    ºÎºÐÀÏÄ¡¹ÝÀÀ
  • reaction period
    ¹ÝÀÀ±â(ÚãëëÑ¢).
  • reaction sequence
    ¹ÝÀÀ¼ø¼­.
  • reaction substance
    ¹ÝÀÀ¹°Áú(ÚãëëÚªòõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • acute apical periodontitis
    ±Þ¼º ±Ù÷¼º Ä¡ÁÖ¿°(¡­ÐÆôÓàõöÍñ²æú).
  • acute appendicitis
    ±Þ¼ºÃæ¼ö¿°.
  • acute appendicitis
    ±Þ¼º Ãæ¼ö¿°(¡­Ãæ¼ö¿°).
  • acute arthritis
    ±Þ¼º °üÀý¿°(ÐáàõÎ¼ï½æú).
  • acute ascending myelitis
    ±Þ¼º »óÇà(¼º) ô¼ö¿°(¡­ß¾ú¼àõô±âÐæú).
  • acute ascending paralysis<³ª> p. ascendens acu ta
    ±Þ¼º »óÇà(¼º) ¸¶ºñ(¡­ß¾ú¼àõ Ýö).
  • acute ataxia
    ±Þ¼º ¿îµ¿½ÇÁ¶(¡­ê¡ÔÑã÷ðà).
  • acute auditory hallucinosis
    ±Þ¼º ȯûÁõ
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(¡­á¬Ð¶àõÎ¼ï½æú).
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(Ðáàõá¬Ð¶àõÎ¼ï½æú).
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°(¡­á¬Ð¶àõãýҮدæú).
  • acute barbiturate intoxication
    ±Þ¼º ¹Ù¸£ºñÅ»Áßµ¶.
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute brain syndrome
    ±Þ¼º ³úÁõÈıº(¡­Òàñøý¦ÏØ).
  • acute bronchitis
    ±Þ¼º ±â°üÁö¿°(¡­Ñ¨Î· ò¨æú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
SPPS solid phase peptide synthesis; stable plasma protein solution
SPR sepiapterin reductase; serial probe recognition; specific pathogen free; Society for Pediatric Radio...
SPRIA solid phase radioimmunoassay
TE exhalation time; expiratory phase time
tG1 the time required to complete the G1 phase of the cell cycle
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
ISPCR i situ polymerase chain reaction
IPCR Inverse polymerase chain reaction
LAR Late asthmatic reaction
LCR late cutaneous reaction
LCR Ligase Chain Reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute hypoxic encephalopathy
    ±Þ¼º Àú»ê¼Ò¼º ³úº´Áõ
  • acute idiopathic thrombocytopenic purpura
    ±Þ¼º Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹Ý º´
  • acute illness
    ±Þ¼º Áúº´, ±Þ¼º Áúȯ
  • acute inclusion body encephalitis
    ±Þ¼º ºÀÀÔü ³ú¿°
  • acute infectious disease
    ±Þ¼º Àü¿°º´
    ¹ßº´ ÈÄ ¼öÀÏ- ¼öÁÖÀÏ·Î Ä¡À¯ ¶Ç´Â »ç¸ÁÇÏ´Â Àü¿°º´. ¾ö¹ÐÇÏ°Ô ±Þ¼º°ú ¸¸¼ºÀ» ±¸º°ÇÒ ¼ö ¾ø´Âµ¥, ÀϹÝÀûÀ¸·Î ¿¬±¸, ´ëÃ¥ÀÇ ÆíÀÇ»ó ºÐ·ùµÈ´Ù. ±Þ¼º Àü¿°º´Àº Áßµ¶ÀÏ °æ¿ì »ç¶÷µéÀÇ ÁÖ¸ñÀ» ¹Þ±â ½±°í, ¿¬±¸, ´ëÃ¥µµ ½Ç½ÃÇϱ⠽±´Ù. ÄÝ·¹¶ó, Æä½ºÆ®, µÎâ, Æú¸®¿À µîÀÌ ±×°ÍÀÌ´Ù. ÇÑÆí °æÁõÀÎ °ÍÀº ±×´ÙÁö Áß¿ä½Ã µÇÁö ¾Ê±â ¶§¹®¿¡ ¿¬±¸, ´ëÃ¥µµ ´Ê¾îÁö°í ÀÖ´Â °ÍÀÌ ¸¹´Ù. ÀÎÇ÷翣ÀÚ, È«¿ª, ¼öµÎ µîÀÌ ±× ¿¹ÀÌ´Ù.
  • acute infectious hemorrhagic fever
    ±Þ¼º °¨¿°¼º ÃâÇ÷ ¿­
  • acute infectious paralysis
    ±Þ¼º Àü¿°¼º ¸¶ºñ
  • acute inflammatory demyelinating polyradiculoneuropathy
    ±Þ¼º ¿°Áõ¼º ´Ù¹ß½Å°æ¿°
    ¾ÆÁ÷µµ È®½ÇÇÏÁö ¾ÊÁö¸¸ ¸é¿ª¹ÝÀÀÀ» ÅëÇÏ¿© ³ªÅ¸³­´Ù°í ¾Ë·ÁÁ® ÀÖ´Â ½Å°æº´ÁõÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ±Þ¼ÓÈ÷ ÁøÇàÇÏ´Â ¿îµ¿½Å°æº´ÁõÀ¸·Î ÇÏÁö¿¡¼­ ½ÃÀÛÇÏ¿© »óÁö·Î ÁøÇàµÇ¸ç, Á¤µµÀÇ Â÷À̸¦ °¡Áø °¨°¢Àå¾Ö¸¦ µ¿¹ÝÇÑ´Ù.
  • acute intermittent porphyria
    ±Þ¼º °£Ç漺 Æ÷ÇÁÇǸ°Áõ
    Æ÷¸£ÇǸ°Áõ °¡¿îµ¥ °¡Àå ¸¹Àº °ÍÀÌ°í ¾à°£ ¿©¼º¿¡°Ô ¸¹Àºµ¥ »ó¿°»öü ¿ì¼º À¯ÀüÀ» ÇÑ´Ù´Â °ÍÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. º¹Åë, ±¸Åä, º¯ºñ µîÀÇ º¹ºÎ Áõ»óÀÌ ±Þ¼º °£Ç漺À¸·Î »ý±â°í ¶§·Î´Â ¼±Åë°ú ºñ½ÁÇÒ ¶§°¡ ÀÖ´Ù. º¹ºÎ Áõ»ó¿¡ À̾î À̸¥¹Ù ´Ù¹ß¼º ½Å°æ¿°°ú °°Àº ½Å°æ Áõ»óÀÌ ³ªÅ¸³ª´Âµ¥, Á¤½Å Áõ»óµµ »ý±â´Â ¼ö°¡ ÀÖ´Ù. ¿ì·ÎÆ÷¸£ÇǸ®³ëÁ¨ 1ÀÇ ÇÕ¼º È¿¼ÒÀÇ À¯ÀüÀû ÀúÇϰ¡ ÀÖ°í Æä³ë¹ÙºñÅ» º¹¿ë µîÀÇ À¯Àο¡ ÀÇÇØ Çð ÇÕ¼ºÀÌ ´õ¿í ³·¾ÆÁö¸é Çǵå¹éÀûÀ¸·Î ¾Æ¹Ì³ë·¹ºê¸°»êÀ̳ª Æ÷¸£Æ÷ºô¸®³ëÁ¨ÀÇ Áõ»óÀÌ »ý±â°í ±× ¶§¹®¿¡ Áõ»óÀÌ ¹ß»ýÇÏ´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù.
  • acute interstitial pneumonitis
    ±Þ¼º °£Áú¼º Æó·Å
  • acute isolated myocarditis
    ±Þ¼º ºÐ¸®¼º ½É±Ù¿°
  • acute lacunar tonsillitis
    ±Þ¼º ¼±¿Í Æíµµ¿°
  • acute laryngotracheal trauma
    ±Þ¼º Èĵαâ°ü ¿Ü»ó
  • acute leukemia
    ±Þ¼º ¹éÇ÷º´
    ¿ø¹ßÇÏ´Â Á¶Ç÷ Á¶Á÷À̳ª ¹éÇ÷º´ ¼¼Æ÷ÀÇ Á¾·ù¿¡ µû¶ó °ñ¼ö¼º, ¸²ÇÁ¼º, ´Ü±¸¼ºÀ¸·Î ³ª´µ¾îÁö°í Ư¼öÇÑ °ÍÀ¸·Î¼­ Àû¹éÇ÷º´, ÇüÁú ¼¼Æ÷¼º ¹éÇ÷º´, È£»ê±¸¼º ¶Ç´Â È£¿°±â¼º ¹éÇ÷º´ µîÀÌ ÀÖ´Ù.
  • acute leukosis
    ±Þ¼º ¹éÇ÷Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
oesophageal stricture, acute A narrowing or closure of the normal opening of the swallowing tube leading to the stomach, usually caused by scarring from acid irritation. Acute, complete obstruction of the oesophagus occurs when food (usually meat) is lodged in the oesophageal stricture. Patients experience chest pain, and are unable to swallow saliva. Attempts to relieve the obstruction by inducing vomiting at home are usually unsuccessful. Patients with complete oesophageal obstruction can breathe, and are not at any risk of suffocation. Endoscopy is usually employed to retrieve the meat and relieve the obstruction.
(12 Dec 1998)
encephalomyelitis, acute disseminated An acute or subacute encephalomyelitis or myelitis characterised by perivascular lymphocyte and mononuclear cell infiltration and demyelination. It occurs most commonly following an acute viral infection, especially measles, but may occur without a recognizable antecedent, and formerly occurred as a complication of rabies and smallpox vaccination.
(12 Dec 1998)
kidney failure, acute A clinical syndrome characterised by a sudden decrease in glomerular filtration rate, often to values of less than 1 to 2 ml per minute. It is usually associated with oliguria (urine volumes of less than 400 ml per day) and is always associated with biochemical consequences of the reduction in glomerular filtration rate such as a rise in blood urea nitrogen (bun) and serum creatinine concentrations.
(12 Dec 1998)
kidney tubular necrosis, acute Acute kidney failure resulting from destruction of tubular epithelial cells. It is commonly attributed to exposure to toxic agents or renal ischemia following severe trauma.
(12 Dec 1998)
leukaemia, erythroblastic, acute A myeloproliferative disorder characterised by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
(12 Dec 1998)
leukaemia, megakaryocytic, acute Nonlymphocytic leukaemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common.
(12 Dec 1998)
leukaemia, myelocytic, acute Progressive, malignant disease of the myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate.
(12 Dec 1998)
leukaemia, nonlymphocytic, acute Acute leukaemia distinguished from acute lymphocytic leukaemia (all) by the morphology of the marrow and blood leukaemic cells. Cytoplasmic granules are usually present and the nucleus is usually large and irregular. Anll is more common in adults than all and occurs at any age.
(12 Dec 1998)
leukoencephalitis, acute haemorrhagic A rare, fatal postinfection or allergic demyelinating disease of the central nervous system having a fulminating course and occurring mainly in young adults. It is characterised by destruction of white matter to the point of liquefaction; widespread necrosis of blood vessel walls leading to the formation of multiple small haemorrhages in the involved areas and the exudation of fibrin into the surrounding tissue; and cellular infiltration of the necrotic areas.
(12 Dec 1998)
liver failure, acute A form of liver failure with rapid onset. It is often induced by the toxic effect of drugs and various toxic substances in experimental studies in animals and in clinical states in humans. If coma ensues, the constellation of neurological symptoms is referred to as hepatic encephalopathy.
(12 Dec 1998)
accelerated reaction A response occurring in a shorter time than expected; the cutaneous manifestations occurring during the period between the second and tenth day following smallpox vaccination; because it is intermediate between a primary reaction and an immediate reaction, it is regarded as evidence of some degree of resistance.
Synonym: vaccinoid reaction.
(05 Mar 2000)
acid reaction Any test by which an acid reaction is recognised such as the change of blue litmus paper to red, an excess of hydrogen ions over hydroxide ions in aqueous solution indicated by a pH value less than 7 (at 22°C).
Compare: dissociation constant of water.
(05 Mar 2000)
addition reaction <chemistry> Any reaction in which two chemicals combine to form a single chemical.
(15 Jan 1998)
adverse drug reaction reporting systems Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.
(12 Dec 1998)
adverse reaction Any undesirable or unwanted consequence of a preventive, diagnostic, or therapeutic procedure or regimen.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á